(Q37965381)

26 August 2017

title

Disarming suppressor cells to improve immunotherapy (English)

1 reference

26 August 2017

1 reference

Theresa L Whiteside

1

1 reference

26 August 2017

publication date

7 December 2011

1 reference

Cancer Immunology, Immunotherapy

26 August 2017

published in

1 reference

26 August 2017

volume

61

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

283-288

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1171-7

26 August 2017

exact match

0 references

cites work

Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Naturally occurring regulatory T cells: recent insights in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Immunostimulation versus immunosuppression after multiple vaccinations: the woes of therapeutic vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

The tumor microenvironment and its role in promoting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

CD39 and control of cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Foxp3+CD4+ T cell-mediated immunosuppression involves extracellular nucleotide catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

CD73: A Novel Target for Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

Role for the cAMP-protein kinase A signaling pathway in suppression of antitumor immune responses by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1171-7

10.1007/S00262-011-1171-7

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference